Andrew Richards is an established biotechnology entrepreneur and investor with extensive experience from the UK biotechnology sector in research, drug development, commercial deals and scale-up of companies. He is the Chairman of Congenica Ltd, Abcodia Ltd, Ieso Digital Health Ltd and Closed Loop Medicine Ltd as well as being a director of Owlstone Medical Ltd, Cancer Research Technology Ltd (the commercial board of Cancer Research UK) and The Scale-Up Institute.
He is a council member of the UK Medical Research Council.
Andrew is a Cambridge graduate with a Ph.D. in enzyme chemistry and was a founder of Chiroscience in 1992 and an Executive Director through to the Celltech deal in 1999. Andrew has a track record as a founder, active investor in and director of more than 25 innovative healthcare and life-science companies, including Vectura plc and Arakis Ltd. He has experience as a board director for several public companies, including Chiroscience plc, Vectura plc, IXICO plc and Silence Therapeutics plc.
This person is not in the org chart
This person is not in any teams